Health Care & Life Sciences » Pharmaceuticals | AcelRx Pharmaceuticals Inc.

AcelRx Pharmaceuticals Inc. | Ownership

Companies that own AcelRx Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
The Vanguard Group, Inc.
1,646,169
2.72%
125,538
0%
06/30/2018
BlackRock Fund Advisors
665,580
1.1%
17,304
0%
06/30/2018
Renaissance Technologies LLC
496,600
0.82%
496,600
0%
06/30/2018
Fidelity Management & Research Co.
298,644
0.49%
273,644
0%
06/30/2018
Geode Capital Management LLC
250,005
0.41%
34,171
0%
06/30/2018
D. E. Shaw & Co. LP
249,992
0.41%
88,170
0%
06/30/2018
Bridgeway Capital Management, Inc.
246,150
0.41%
-33,000
0.01%
06/30/2018
Susquehanna Financial Group LLLP
144,074
0.24%
35,330
0%
06/30/2018
Citadel Advisors LLC
119,363
0.2%
45,528
0%
06/30/2018
Goldman Sachs & Co. LLC (Private Banking)
115,184
0.19%
100,964
0%
06/30/2018

About AcelRx Pharmaceuticals

View Profile
Address
351 Galveston Drive
Redwood City California 94063
United States
Employees -
Website http://www.acelrx.com
Updated 07/08/2019
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of acute pain. Its products include DSUVIA and ZALVISO. The company was founded by Thomas A.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.